# Thermetrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thermetrix

- Industry: Medical Devices & Equipment
- Headquarters: Abercynon, UK
- Website: www.thermetrix.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Jan 2, 2019)
- Investors on record: 1

## About

Thermetrix Limited specializes in advanced thermal imaging solutions, focusing on foot health diagnostics through the innovative Podium System, which aids healthcare professionals in detecting conditions such as diabetic foot ulcers and vascular deficiencies.Founded in 2016 and headquartered in Abercynon, UK, Thermetrix Limited develops thermal imaging technology for healthcare. The company raised GBP 0.50 million in Seed funding on January 2, 2019, from the Development Bank of Wales and individual investors. The CEO is Russell Payne, who leads the company in delivering solutions aimed at foot health management.Thermetrix Ltd. specializes in advanced thermal imaging technology through its core offering, the Podium System, designed to assess foot health. The Podium System utilizes thermography to identify abnormal temperature profiles in patients’ feet, which can indicate conditions such as diabetic foot ulcers, vascular deficiencies, and inflammation. This technology plays a critical role in diabetic foot care management, allowing healthcare professionals to create informed treatment plans that may include the use of orthotics and other interventions. The primary customer base consists of healthcare providers, including podiatrists and clinics, primarily in the United Kingdom and Europe, as well as select markets in North America and Asia. The company has received endorsement from the Royal College of Podiatry, enhancing its credibility and reach within the healthcare sector.Thermetrix Ltd. generates revenue through direct sales and partnerships with healthcare professionals and institutions utilizing the Podium System. The business model is structured around both individual product sales and potential subscription services for ongoing thermal scanning and monitoring. The flagship product, Podium Professional, is positioned as a crucial tool for clinics in preventing the progression of foot-related health issues, thereby reducing the need for surgical interventions. The transactional framework includes agreements with healthcare providers, where they purchase the Podium System for in-clinic use, supplemented by service contracts for maintenance and updates.Thermetrix Limited aims to enhance its product portfolio with new advancements in thermal imaging technology, though specific product launches are yet to be announced. The company is targeting expansion into additional European markets, with plans to begin this process by 2024. The recent Seed funding of GBP 0.50 million will support these initiatives, allowing Thermetrix to refine its offerings and scale operations to meet growing demand.

## Funding rounds

- Seed, Jan 2, 2019, $0.6M — Development Bank of Wales
- Seed, Mar 9, 2018, $0.7M — Development Bank of Wales

## Investors

- Development Bank of Wales (https://capitalatlas.ai/funds/development-bank-of-wales) — Seed